Bivalirudin is widely used as an anticoagulant during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction. However, an increase in acute stent thrombosis rates has been found in the…
Advanced atherosclerotic disease increases the risk of stent thrombosis after drug-eluting stent (DES) implantation. We aimed to determine if an abnormal ankle–brachial index (ABI) value as a surrogate of atherosclerotic…
Drug-eluting stents effectively inhibit neointimal hyperplasia within the first year, thereby reducing the need for repeat revascularization. However, a delayed pattern of restenosis might be more prominent in drug-eluting stents…
The impact of a coronary revascularization strategy (early or deferred) on clinical outcomes of non–ST-segment elevation acute coronary syndrome (NSTE-ACS) has not been well established. The goal of this study…
Vascular complications are the most frequent adverse events associated with percutaneous coronary interventions (PCIs) leading to an increase in morbidity and mortality. Puncture of the common femoral artery in its…
We read the interesting report by Szwast et al in a recent issue of The American Journal of Cardiology . The investigators analyzed the predictors of survival after biventricular repair…
The future of cardiology rests in the hands and minds of cardiovascular trainees and fellowship programs. Education and training is rapidly changing, and the paradigm of “see one, do one,…
Obesity is associated with increased risk for cardiovascular (CV) disease (CVD) and CV mortality. Bariatric surgery has been shown to resolve or improve CVD risk factors, to varying degrees. The…
When I became editor of The American Journal of Cardiology in June 1982, I thought that it might be useful for the readers and authors to have some idea of…
The term “coronary instability” commonly refers to the sequence of events that lead from plaque erosion or rupture to the occurrence of acute coronary syndromes (ACS). However, evidence indicates that…
